Scientists Discover Rejuvenating Protein That Helps Aging Brain Cells Act Young Again

In a study published in Nature Communications, researchers found that removing TIMP2 caused microglia—the brain’s immune cells—to develop characteristics associated with aging and neurodegenerative disease. When scientists restored TIMP2 in the bloodstream of older mice, the microglia became more effective at clearing cellular debris and showed fewer molecular signs of inflammation and other potentially harmful changes.

The findings suggest that proteins associated with youth may help maintain the brain’s natural defenses during aging. TIMP2 may be an important factor in supporting healthy immune activity in the brain.

Why Do Brain Immune Cells Become Less Effective With Age?

Aging is the largest known risk factor for Alzheimer’s disease and other neurodegenerative diseases. However, scientists still do not fully understand the biological processes that make the aging brain increasingly vulnerable to these conditions.

One key part of the process involves microglia, specialized immune cells that act as the brain’s maintenance and defense system. They remove cellular waste, help maintain the networks through which neurons communicate, and respond when brain tissue is damaged.

As the brain ages, microglia can lose some of their ability to perform these essential tasks. This decline may contribute to conditions that promote inflammation and interfere with normal brain function.

“TIMP2 promotes the healthy functioning of immune cells in the brain,” said Joseph M. Castellano, Ph.D., associate professor of neuroscience at the Ronald M. Loeb Alzheimer’s Disease Center and the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai and corresponding author of the study.

“TIMP2 may help restore aspects of microglial function that are impaired with age by supporting the ability of microglia to clear debris and limit maladaptive responses. Because our previous studies identified TIMP2 as a regulator of extracellular matrix-mediated synaptic plasticity, these findings suggest that this factor is located at the intersection of several processes important for normal brain function.”

Synaptic plasticity is the brain’s ability to strengthen or weaken connections between neurons, a process essential for learning and memory. The extracellular matrix is a network of molecules surrounding cells that helps support and regulate cellular activity.

What Happens When the Brain Loses TIMP2?

To investigate how TIMP2 affects brain immune cells, the research team studied several groups of mice representing different biological conditions. The study included first author Dr. Brittany Hemmer, who was a graduate student in Castellano’s lab during the research.

Some mice were genetically modified to lack systemic TIMP2. In other experiments, researchers specifically removed the protein from either microglia or neurons. By comparing these models, the team examined how TIMP2 affects immune cell behavior in healthy and aging brains.

Scientists used several advanced techniques to study the changes. Single-nucleus RNA sequencing allowed them to examine gene activity patterns in individual cell nuclei. The researchers also used detailed imaging, functional tests, and in vivo microdialysis, a technique that collects and measures substances in the fluid surrounding cells in living brain tissue.

The absence of TIMP2 produced significant changes. Microglia developed several characteristics typically associated with aging and brain injury. Their cellular activation markers changed, their ability to clear debris declined, and they displayed molecular signatures associated with cellular senescence, a condition linked to aging and cellular stress.

The effects extended beyond the immune cells themselves. Using in vivo microdialysis, researchers detected higher levels of proteins associated with inflammation and stress in the extracellular environment surrounding brain cells.

Taken together, the findings indicate that TIMP2 helps prevent microglia from transitioning into a potentially harmful state.

Restoring TIMP2 Improves Aging Brain Cells in Mice

The researchers next examined whether providing TIMP2 could counteract some of the changes associated with aging.

They injected TIMP2 into older mice, allowing the protein to circulate throughout the body. The treatment produced promising results in the animal model.

Microglia became more effective at removing cellular debris and showed lower levels of molecular markers associated with inflammation. In other words, restoring this youth-associated protein helped aging immune cells recover some functions that normally decline over time.

These improvements suggest that TIMP2 influences how microglia respond to conditions in the brain. The protein may help maintain a healthier environment for nerve cells by supporting protective activities and limiting potentially harmful reactions.

The findings also point to a possible biological connection between circulating factors associated with youth and the activity of the brain’s innate immune system, which provides an initial defense against injury and other threats.

What This Could Mean for Brain Aging and Alzheimer’s Research

The discovery has generated interest in how biological factors associated with youth may influence the aging process.

Because microglia help maintain brain health, finding ways to preserve their normal function could provide important insights into age-related neurological diseases. Changes in microglial activity may contribute to harmful inflammation and other processes linked to brain aging.

“Although additional research is needed, this study provides new insights into how youth-related factors influence pathways involved in brain aging and age-related neurological diseases, and may ultimately inform therapeutic strategies,” Dr. Castellano said.

However, the researchers cautioned that the findings came from experiments in mice. It remains unclear whether TIMP2 produces similar effects in humans or whether manipulating the protein could lead to effective treatments.

Additional research is needed to determine whether TIMP2 itself, or the biological pathways it controls, can be targeted to reduce the harmful changes associated with brain aging.

For now, the findings offer a promising explanation for how youth-associated proteins may help maintain the brain’s immune defenses and how restoring them could recover some functions weakened with age.

This research was supported by the National Institute on Aging (R01AG061382 [JMC], RF1AG072300 [JMC], 1F31AG079604-01A1 [BMH], T32AG049688 [BMH, SMP], R01AG061382-02S1 [JMC, SMP]) and the Alzheimer’s Disease Treatment Fund (JMC).